John Paulson Portfolio

John Paulson’s investment portfolio highlights a concentrated focus on high-conviction, event-driven and commodity/biopharma-linked stocks, reflecting a preference for assets with asymmetric risk/reward potential. The top five stock investments in his portfolio are:
1) Perpetua Resources Corp — Investment exposure to precious metals development and early-stage resource growth; aligns with Paulson-style bet on upside from commodity price movements and operational milestones.
2) Madrigal Pharmaceuticals Inc — Biopharma investment centered on therapies targeting major chronic disease pathways; reflects willingness to back clinical and commercial catalysts typical of high-impact healthcare stocks.
3) Bausch Health Companies Inc — Turnaround and value-oriented healthcare investment profile, with the potential for re-rating as debt discipline, product execution, or profitability improves—consistent with opportunistic equity investing.
4) International Tower Hill Mines Ltd — Resource-focused investment tied to gold/mining economics, suited to investor interest in durable demand drivers and leverage to metal prices within mining stocks.
5) Novagold Resources Inc. — Gold-related investment designed for torque to bullion market conditions, supported by development progress expectations; fits a broader Paulson portfolio approach emphasizing commodity-linked equities.
Overall, this set of stocks underscores John Paulson’s investment strategy: targeted bets across biotech innovation and natural-resources upside, using diversified yet conviction-led positioning within key sectors of his portfolio.